Jaikrishna Patel serves as Executive at NephroGenex, Inc., where they oversee executive responsibilities. Since joining the company, Jaikrishna Patel has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 10, 2015 involved receiving (via award) 97,306 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 10, 2015 | NRX | $0 | Award | 97,306 | $N/A | Discretionary |
Jaikrishna Patel currently holds 97,306 shares of NephroGenex, Inc. (NRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jaikrishna Patel has been a net neutral trader of NRX stock. They have purchased $0 and sold $0 worth of shares.
Jaikrishna Patel's most recent insider trade was on Nov 10, 2015, when they sold 97,306 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted